Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological and Behavioral Treatment of Opioid Use Disorder
Mehmet Sofuoglu, Elise E. DeVito, Kathleen M. Carroll
Psychiatric Research and Clinical Practice (2018) Vol. 1, Iss. 1, pp. 4-15
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Suicide Risk and Addiction: The Impact of Alcohol and Opioid Use Disorders
Mina Rizk, Sarah Herzog, Sanjana Dugad, et al.
Current Addiction Reports (2021) Vol. 8, Iss. 2, pp. 194-207
Open Access | Times Cited: 90
Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms
Peter Treitler, Cadence F. Bowden, James F. Lloyd, et al.
Journal of Substance Abuse Treatment (2021) Vol. 132, pp. 108514-108514
Open Access | Times Cited: 54
A scoping review of alcohol, tobacco, and other drug use treatment interventions for sexual and gender minority populations
Jeremy D. Kidd, Margaret M. Paschen-Wolff, Amy A. Mericle, et al.
Journal of Substance Abuse Treatment (2021) Vol. 133, pp. 108539-108539
Open Access | Times Cited: 47
Fentanyl and Other Opioid Use Disorders: Treatment and Research Needs
Nora D. Volkow, Carlos Blanco
American Journal of Psychiatry (2023) Vol. 180, Iss. 6, pp. 410-417
Closed Access | Times Cited: 18
Patent review of novel compounds targeting opioid use disorder (2018-2024)
Samuel Obeng, Lance Richard McMahon, Edward Ofori
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Technologies for Opioid Use Disorder Management: Mobile App Search and Scoping Review
Joseph Nuamah, Ranjana K. Mehta, Farzan Sasangohar
JMIR mhealth and uhealth (2020) Vol. 8, Iss. 6, pp. e15752-e15752
Open Access | Times Cited: 44
Feasibility and acceptability of a novel digital therapeutic combining behavioral and pharmacological treatment for opioid use disorder
Laura B. Monico, Megan Eastlick, Darcy Michero, et al.
Digital Health (2024) Vol. 10
Open Access | Times Cited: 4
Noninvasive Brain Stimulation for Opioid Use Disorder: An Update of the Literature
Sophia H. Blyth, Carri S. Polick, L. Kim, et al.
Current Behavioral Neuroscience Reports (2025) Vol. 12, Iss. 1
Closed Access
Medicine vs. Myth: Exploring the Therapeutic Potential of Cannabis for Opioid Use Disorder and Pain
Pooja R. Sarkar, Charlene D. Vincent, Anthony Szeto, et al.
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access
“It's more than just the act of not using. It's a feeling of finally completing something.”: Person-centered definitions of successful treatment outcomes from patients and staff at a methadone treatment program in Baltimore City
Valerie D. Bradley, Mary B. Kleinman, Morgan S. Anvari, et al.
Journal of Substance Use and Addiction Treatment (2025), pp. 209683-209683
Closed Access
Qualitative analysis of a patient's experience of ketamine-assisted psychotherapy for substance use disorder: Empirical synergies with twelve-step programs
Dan Petrovitch, Jacob Spinks, H.J. Yoo, et al.
Psychiatry Research Case Reports (2025), pp. 100259-100259
Open Access
Novel therapeutics in development for the treatment of stimulant-use disorder
Erica J. Young, László Radnai, В. А. Приходько, et al.
Current Opinion in Neurobiology (2024) Vol. 87, pp. 102898-102898
Open Access | Times Cited: 3
Nutritional implications of opioid use disorder: A guide for drug treatment providers.
Melody N. Chavez, Khary K. Rigg
Psychology of Addictive Behaviors (2020) Vol. 34, Iss. 6, pp. 699-707
Closed Access | Times Cited: 28
The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: A systematic review
Stephanie Lake, Michelle St. Pierre
Clinical Psychology Review (2020) Vol. 82, pp. 101939-101939
Closed Access | Times Cited: 28
Using machine learning to study the effect of medication adherence in Opioid Use Disorder
David Warren, Amir Marashi, Arwa Siddiqui, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0278988-e0278988
Open Access | Times Cited: 18
Single cell transcriptomics reveals distinct transcriptional responses to oxycodone and buprenorphine by iPSC-derived brain organoids from patients with opioid use disorder
Ming‐Fen Ho, Cheng Zhang, Irene Moon, et al.
Molecular Psychiatry (2022) Vol. 29, Iss. 6, pp. 1636-1646
Open Access | Times Cited: 17
Physicians’ experiences with buprenorphine: A qualitative study of motivations for becoming X waivered and barriers to and facilitators of prescribing the medication for opioid use disorder
C. Greer McCollum, Ellen Eaton, Thomas Creger, et al.
Drug and Alcohol Dependence (2023) Vol. 244, pp. 109777-109777
Closed Access | Times Cited: 8
Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies
João P. De Aquino, Suprit Parida, Victor J. Avila‐Quintero, et al.
Drug and Alcohol Dependence (2021) Vol. 228, pp. 109097-109097
Open Access | Times Cited: 19
Changes in the availability of medications for opioid use disorder in prisons and jails in the United States during the COVID-19 pandemic
David Dadiomov, Rebecca Trotzky‐Sirr, Andrew Shooshtari, et al.
Drug and Alcohol Dependence (2022) Vol. 232, pp. 109291-109291
Open Access | Times Cited: 13
Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies
João P. De Aquino, Anees Bahji, Óscar Gómez, et al.
Drug and Alcohol Dependence (2022) Vol. 241, pp. 109702-109702
Open Access | Times Cited: 12
Ambivalence and contingencies: A qualitative examination of peer recovery coaches' attitudes toward medications for opioid use disorder
Emily Pasman, Sydney O’Shay, Suzanne Brown, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 155, pp. 209121-209121
Closed Access | Times Cited: 7
Whole-Body Vibration Prevents Neuronal, Neurochemical, and Behavioral Effects of Morphine Withdrawal in a Rat Model
Gavin C. Jones, Christina A. Small, Dallin Z. Otteson, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14147-14147
Open Access | Times Cited: 7
Treatment for opioid use disorder in the Florida medicaid population: Using a cascade of care model to evaluate quality
Kimberly Johnson, Holly A. Hills, Jifeng Ma, et al.
The American Journal of Drug and Alcohol Abuse (2020) Vol. 47, Iss. 2, pp. 220-228
Open Access | Times Cited: 20
The potential role of opioid vaccines and monoclonal antibodies in the opioid overdose crisis
Suky Martinez, Hannah Harris, Thomas Chao, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 3, pp. 181-185
Open Access | Times Cited: 6
Multiobjective Molecular Optimization for Opioid Use Disorder Treatment Using Generative Network Complex
Hongsong Feng, Rui Wang, Chang‐Guo Zhan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 12479-12498
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top